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Abstract—The formation of bone-like tissue from human
mesenchymal stem cells (hMSC) cultured in osteogenic
medium on silk ﬁbroin scaffolds was monitored and quan-
tiﬁed over 44 days in culture using non-invasive time-lapsed
micro-computed tomography (lCT). Each construct was
imaged nine times in situ. From lCT imaging, detailed
morphometrical data on bone volume density, surface-to-
volume ratio, trabecular thickness, trabecular spacing, and
the structure model index and tissue mineral density were
obtained. lCT irradiation did not impact the osteogenic
performance of hMSCs based on DNA content, alkaline
phosphatase activity, and calcium deposition when compared
to non-exposed control samples. Bone-like tissue formation
initiated at day 10 of the culture with the deposition of small
mineralized clusters. Tissue mineral density increased linearly
over time. The surface-to-volume ratio of the bone-like
tissues converged asymptotically to 26 mm-1. Although
in vitro formation of bone-like tissue started from clusters,
the overall bone volume was not predictable from the time,
number, and size of initially formed bone-like clusters. Based
on microstructural analysis, the morphometry of the tissue-
engineered constructs was found to be in the range of human
trabecular bone. In future studies, non-invasive, time-lapsed
monitoring may enable researchers to culture tissues in vitro,
right until the development of a desired morphology is
accomplished. Our data demonstrate the feasibility of qual-
itatively and quantitatively detailing the spatial and temporal
mineralization of bone-like tissue formation in tissue engi-
neering.
Keywords—Tissue engineering, Bone, Micro-computed
tomography, Human mesenchymal stem cells, Silk, Scaffold.
INTRODUCTION
Bone tissue engineering is a ﬁeld of increasing
interest in orthopedics.1,12,20,33 In particular the use of
in vitro-engineered bone tissues offers the opportunity
to substitute malfunctioning, injured, or diseased tissue
in patients suffering from degenerative diseases or tu-
mors. Tissue engineering of skeletal tissues generally
requires at least three elements: (i) three-dimensional
scaffolds, (ii) cells, and (iii) bioreactors with appro-
priate media, to form tissues such as bone, cartilage, or
even osteochondral plugs.5,7,19,26,32,33 Engineered con-
structs have the potential to replace compromised or
missing host tissue or to serve for extended in vitro
studies of bone formation in well-controlled settings.
Mesenchymal stem cells derived from human bone
marrow (hMSC) are a well-known cell source to engi-
neer autologous bone tissues. They can be expanded to
large cell numbers in an undiﬀerentiated state and,
when exposed to the appropriate extrinsic signals,
selectively diﬀerentiate along mesenchymal lineages,
including cartilage and bone.25 Scaffolds prepared from
silk ﬁbroin (SF) have shown promising results as sub-
strates for in vitro and in vivo culture of bone-like tissue.
The quality of the bone-like tissue was conﬁrmed by
biochemical assays, histology, gene expression assays,
X-ray diffraction analysis, and lCT.15,17,20 SF scaffolds
demonstrated equivalent or better biocompatibility
than type I collagen scaffolds, and distinguished
mechanical strength and mechanical integrity as com-
pared to other commonly used degradable polymeric
biomaterials.17,19,20 Furthermore, the degradation of
SF scaffolds is slow, a prerequisite for the present study
aiming at imaging and quantifying bone-like tissue
formation on a stable, yet degradable system. Faster
degradation rate as observed for type I collagen would
impact the ordered formation of bone-like tissues and,
therefore, the demonstration of feasibility for time-
lapsed bone visualization sought in the present study,
due to disintegration of the substrate during cell growth
and tissue formation. To seed cells on SF scaffolds
Matrigel was chosen. Matrigel is a solubilized basement
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membrane matrix which supports the growth and dif-
ferentiation of different cell types but does not contain
osteogenic inducers.2 In previous studies the combina-
tion of Matrigel-based seeding and SF scaffolds proved
to be successful for the settlement of hMSC and the
subsequent deposition of bone-like tissue.11
At present, assessments of in vitro-engineered tissue
quality and quantity rely on destructive methods,
thereby terminating cultures and necessitating multiple
samples for adequate statistical analysis. Obviously
this requirement also hinders the understanding of
dynamic tissue formation processes for individual
specimens and information is generally taken from
pooled samples forming a treatment group.19,20,31,35
Future clinical supply scenarios will require quality
assessment of the selected implant, rather than retro-
spective data obtained from destructive analysis or
from pooled samples as is currently the state of the art.
Automated, well-controlled bioreactors can potentially
be coupled to non-invasive imaging setups, thereby
providing the necessary information of tissue quality
and formation during culture for implants.16
The goal of this study was to monitor non-inva-
sively and temporally the development of bone-like
tissue, engineered from hMSCs, by the integral use of
micro-computed tomography (lCT). Novel illustra-
tions of growing bone-like tissue and individual
quantiﬁcation concerning bone volume density, sur-
face-to-volume ratio, trabecular thickness, trabecular
spacing, the structure model index, and tissue mineral
density of the constructs were provided. Hence, the
formation of engineered bone-like tissue from hMSCs
on SF scaﬀolds could be directly compared to physi-
ological values. In the future, this or similar imaging
techniques should facilitate the assessment and selec-
tion of constructs from a pool of autologous-engi-
neered implants based on qualitative and quantitative
yet non-destructive imaging regimens.
MATERIALS AND METHODS
Materials
Cocoons from Bombyx mori were kindly provided
by Trudel Inc. (Zurich, Switzerland). Bone morpho-
genetic protein-2 (BMP-2) was kindly provided by
Wyeth (Madison, NJ). Sodium Carbonate (Na2CO3),
Lithium Bromide (LiBr), and 1,1,1,3,3,3-Hexaﬂuoro-
isopropanol (HFIP) were from Fluka (Buchs, Swit-
zerland). Bone marrow was from Cambrex (#1M-125,
Walkersville, MD). Ascorbic acid-2-phosphate, dexa-
methasone, ß-glycerolphosphate, and alkaline phos-
phatase (AP) assay were from Sigma-Aldrich (St.
Louis, MO). Trichloroacetic acid was from Haenseler
(Herisau, Switzerland). Calcium quantiﬁcation assay
was from Rolf Greiner Biochemica (#G210117, Flacht,
Germany). Antibodies CD31-PE, CD34-APC, CD44-
FITC, CD105-FITC, aVbI-FITC, and Matrigel were
from BD Biosciences (San Jose, CA). Triton X-100
was from Biospec Products (Bartlesville, OK). All
other substances were obtained from Invitrogen
(Carlsbad, CA).
Scaﬀold Production
Puriﬁed silkworm ﬁbroin was prepared and formed
into porous scaﬀolds as previously described.23 In
brief, cocoons from B. mori were boiled for 1 h in an
aqueous solution of 0.02 M Na2CO3, and rinsed with
water to extract sericin and other contaminating pro-
teins. Puriﬁed SF was solubilized in 9 M LiBr solution
and dialyzed (Pierce 3500 MWCO, Woburn, MA)
against water. The water was exchanged ﬁve times in
72 h resulting in a SF concentration of approximately
3% (w/v). The SF solution was lyophilized (Christ,
Osterode, Germany) and afterwards dissolved in HFIP
resulting in a 17% (w/v) solution. Granular NaCl was
characterized for size using a sieving tower (Retsch,
Arlesheim, Switzerland). The range of sizes of the
employed porogen NaCl was 224–300 lm. For each
scaffold, NaCl was weighed in a Teﬂon container and
SF/HFIP solution was added at a ratio of 20:1 (NaCl/
SF). HFIP was allowed to evaporate for 2 days and
the NaCl/silk blocks were immersed in 90% (v/v)
methanol for 30 min to induce a protein conforma-
tional transition to b-sheet.23 The blocks were re-
moved, dried, and NaCl was extracted in water for
2 days. Disk-shaped scaffolds (5 mm diameter, 1 mm
thick) were prepared using a dermal punch and auto-
claved.
Cell Isolation and Expansion
Cell isolation was performed as previously
described.19 Brieﬂy, samples of bone marrow were di-
luted in Roswell Park Memorial Institute (RPMI)
medium supplemented with 5% fetal bovine serum
(FBS). The cells were centrifuged at 300 · g for
10 min. Pelleted cells were resuspended in expansion
medium (Dulbeccos Modiﬁed Eagle Medium
(DMEM), 10% FBS, penicillin-streptomycin, fungi-
zone, 1% non-essential amino acids (NEAA), 1 ng/mL
basic ﬁbroblast growth factor (bFGF)) and seeded in
175-cm2 ﬂasks (Nunc, Roskilde, Denmark) at a density
of 5 · 104 cells/cm2. The adherent cells were allowed
to reach 80% conﬂuence (12–17 days for the ﬁrst
passage). Cells were trypsinized and replated every
6–8 days at 80% conﬂuence. The second passage (P2)
cells were used for tissue culture.
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The hMSC were characterized with respect to (i) the
expression of surface antigens and (ii) the ability to
selectively diﬀerentiate along the chondrogenic and
osteogenic lineages. The expression of the following ﬁve
surface antigens was characterized by ﬂow cytometry
analysis (BD Biosciences FACScalibur, San Jose, CA),
as described previously19: CD31 (PECAM-1/endothe-
lial cells), CD34 (sialomucin/hematopoietic precur-
sors), CD44 (hyaluronic acid receptor/hematopoietic
cells and MSC), CD105 (endoglin/endothelial cells and
MSC), and aVbI (immunocells and MSC). To assess the
potential of hMSC for osteogenic and chondrogenic
differentiation, the cells were cultured in 12-well plates
(TPP, Trasadingen, Switzerland) as micro-mass
cultures (5 drops of 15 lL of 2 · 107 cells/mL per well)
in either control medium (DMEM supplemented with
10% FBS, 1% penicillin-streptomycin, 0.2% fungi-
zone, 50 lg/mL ascorbic acid-2-phosphate, and 10 nM
dexamethasone) or osteogenic medium (control med-
ium supplemented with 7 mM ß-glycerolphosphate,
and 1 lg/mL BMP-2) or chondrogenic medium (con-
trol medium supplemented with 1% NEAA, 5 lg/mL
insulin, and 5 ng/mL transforming growth factor beta
(TGF-b1)). Medium was exchanged three times per
week. After 2 weeks of culture the amounts of DNA,
AP activity, glycosaminoglycans (GAG), and calcium
were measured, as described previously.19
Tissue Culture
For cultivation on SF scaﬀolds (5 mm diame-
ter · 1 mm thick disks), P2 hMSC were suspended in
liquid Matrigel (106 cells per scaffold in 10 lL Matri-
gel) while working on ice to prevent gelation, and the
suspension was seeded onto prewetted scaffolds
(overnight incubation of scaffold in DMEM). Seeded
constructs (in culture dishes, without added medium)
were placed in an incubator at 37 C for 15 min to
allow gel hardening before placement in the culture
vials.
Custom culture vials from poly(ether imide) (PEI)
were used to host the constructs during culture. These
vials enabled tissue culture due to their biocompati-
bility,30 while also allowing sterile lCT imaging of the
constructs in a ﬁxed position. The constructs were
cultured in the incubator and could be taken out of the
incubator and transferred to the lCT (Scanco Medical
lCT 40, Bassersdorf, Switzerland) for imaging without
disturbing the scaffold system. During the imaging
process, the vials were completely closed to maintain
sterility for approximately 1 h, while gas exchange was
provided during culture in the humidiﬁed incubator
(37 C, 5% CO2). The constructs could be returned to
the incubator after each lCT scan without terminating
the culture. Five constructs were placed in each vial.
The samples were positioned at a distance of 9 mm to
each other. To eliminate differences in environmental
factors several samples were placed in each vial. Four
vials were used for the biochemical assessment of the
non-scanned control group, four vials were scanned
from day 7 through day 28 and used for biochemical
assessment of the scanned group, and three vials were
scanned from day 7 through day 44 and used for lCT-
based morphology assessment. The vials were ﬁlled
with 5 mL of osteogenic medium as detailed above and
the medium was replaced three times per week for
44 days of cultivation. As demonstrated in earlier
studies, using the same type of scaffolds, this formu-
lation of osteogenic medium does not result in spon-
taneous precipitation of minerals.15,18
Micro-Computed Tomography
In situ lCT images were taken at days 7, 10, 14, 17,
21, 24, 28, 37, and 44 of the culture. Constructs were
monitored with a lCT imaging system (ScancoMedical
lCT 40, Bassersdorf, Switzerland) providing an iso-
tropic resolution of 36 lm. Energy was set to 40 kVp,
integration time was 200 ms, two-fold frame averaging
was chosen. A constrained Gaussian ﬁlter was used to
partly suppress noise. Mineralized tissue was seg-
mented from non-mineralized tissue using a global
thresholding procedure.29 All samples were processed
by using the same ﬁlter width (1.2), ﬁlter support (1),
and threshold (20.7% of maximal image gray value
corresponding to a hydroxyapatite density equivalent
of 130 mgHA/ccm). This threshold was chosen as it
allowed the segmented images to best resemble the
mineralized structures visible by eye from the gray
value images.
Using direct microstructural bone analysis quanti-
tative morphometry indices as known from human
bone biopsy analysis were assessed9: bone volume
(BV), bone volume density (BV/TV, where TV is the
volume of the whole examined sample), bone surface-
to-volume ratio (BS/BV), trabecular thickness (Tb.Th),
trabecular spacing (Tb.Sp), and structure model index
(SMI, which estimates the plate-rod characteristic of a
structure10). For the assessment of tissue mineral
density, the gray value images were correlated to cali-
brated gray values of hydroxyapatite phantoms pro-
vided by the lCT manufacturer. Therefore, a gray
value in an image could be directly expressed as a
hydroxyapatite density equivalent. Tissue mineral
density was determined only within the segmented
bone volume; all non-mineralized regions were ex-
cluded from the analysis and two voxels were peeled
from the surface of the bone volume beforehand to
exclude partial volume effects as recommended by the
lCT manufacturer.
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Three-dimensional visualizations were generated
using AVS/Express (Advanced Visual Systems, Wal-
tham, MA) and in-house software.21,22 To visually
monitor the growth of the bone-like tissue, the subse-
quence of images was superimposed and volumes im-
aged at different times were illustrated by different
colors and degrees of transparency.
Eﬀect of lCT Imaging on Cell Performance
After 28 days of culture and 7 lCT scans, samples
from the imaged group were compared to samples
from a non-imaged control group to check for a pos-
sible eﬀect of the lCT irradiation on the tissue. This
was based on biochemical analysis and on lCT. For
determination of DNA content, ten constructs per
group were disintegrated in 0.1% Triton X-100 solu-
tion using steel balls and a minibead beater (Biospec
Products, Bartlesville, OK). The content of each group
was transferred to a new tube and centrifuged at
300 · g for 10 min at 4 C. The resulting supernatant
was used for the PicoGreen DNA quantiﬁcation assay,
according to the manufacturers protocol. Aliquots
from the same tubes were used to measure the AP
activity using a commercially available assay based on
conversion of p-nitrophenyl phosphate to p-nitrophe-
nol. For determination of calcium content, ten con-
structs per group were disintegrated twice in
2 · 0.5 mL 5% trichloroacetic acid using steel balls
and a minibead beater. After centrifugation at
3000 · g for 10 min at 4 C, the supernatant was as-
sessed spectrophotometrically at 575 nm following the
reaction with o-cresolphthalein complexone according
to the manufacturers protocol. For the lCT analysis
of the formerly non-irradiated samples, samples were
imaged at day 28 of culture and post-processed as
described above. The parameters BV/TV, BS/BV,
SMI, Tb.Th, and Tb.Sp were used for comparison.
Statistical Analysis
Data are presented as mean ± standard deviation
and statistical analysis of data was performed by Stu-
dents t-test using Microsoft Excel. Values of p £ 0.05
were considered signiﬁcant, and p £ 0.01 were consid-
ered highly signiﬁcant.
RESULTS
Characterization of hMSC
Surface antigen expression demonstrated that the
cells were positive for CD105, integrin aVbI and, to a
lesser extent, CD44. Negative expression of surface
antigens for CD31 and CD34 suggested the absence of
cells of endothelial or hematopoietic origin.
Culture-expanded hMSC maintained their ability to
selectively undergo chondrogenic and osteogenic dif-
ferentiation, as assessed biochemically. Micro-mass
cultures of P2 and P3 hMSC cultured for 2 weeks in
osteogenic medium showed higher degrees of AP
activity as compared to cells cultured in chondrogenic
medium. Calcium deposition was observed in osteo-
genic medium, but not in control medium. GAG
accumulation was strikingly higher in chondrogenic
medium when compared to control medium. AP
activity and the amounts of calcium and GAG in mi-
cro-mass cultures of P2 and P3 cells were comparable.
Importantly, cultures of hMSC deposited chondro-
genic markers only when cultured in chondrogenic
medium and osteogenic markers only when cultured in
osteogenic medium.
Bone Volume and Bone Volume Density
Trabecular bone-like tissue formation was observed
with lCT (Figs. 1 and 2). BV increased over time with
high standard deviations starting off at
0.04 ± 0.04 mm3 at day 10 up to 3.8 ± 2.5 mm3 at
day 44 (Fig. 3a). For pooled samples, BV as a function
of time followed an exponential pattern, with
BV(t[day]) = 0.0046e0.226t mm3 (R2 = 96.8%) up to
day 24, followed by a linear deposition up to day 44
with BV(t[day]) = (0.15t - 2.7) mm3 (R2 = 99.6%).
Individual samples followed different growth trends
over time, ranging from strictly linear patterns
(R2 = 99.6%) to exponential patterns (R2 = 96.4%)
over 44 days (Figs. 1c and 3a).
BV was visualized in superimposed maps as a
function of time (BV after 14, 28, and 44 days are
displayed in blue, green, and red, respectively; Fig. 2).
Heterogeneity in BV was corroborated and BV after
44 days in culture was found to be non-predictable
from BV at early time points (R2 = 7% for linear
regression between BV(day 14) and BV(day 44)). Tis-
sue formation originated from clusters at the outer
scaffold rims and proceeded towards the scaffold
center. Over time, continued formation of new bone-
like tissue clusters was observed as indicated by red
spots (end point day 44) in the cross-sectional and side
view (Fig. 2). No signs of slowing of the osteogenic
process were seen even at day 44.
Since the volume of the whole examined samples
(TV) did not vary within this study, the normalized
index bone volume density (BV/TV) showed the same
pattern as BV and is given for comparison (Fig. 3a).
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Bone Surface-to-Volume Ratio
A continuous decrease of the mean bone surface-to-
volume ratio (BS/BV) was observed over time (from
80.0 mm-1 at day 10 to 26.1 mm-1 at day 44) (Fig. 3b).
BS/BV coefﬁcient of variation declined over time,
from 64% at day 10 to 21% at day 44. Evidence was
provided that all samples, regardless of the initial
BS/BV value, asymptotically approached a ﬁnal
value of 26 ± 5 mm-1 (Fig. 3b). The general trend
for the pooled data followed an exponential pattern
withBS/BV(t[day]) = 90.8e-0.031t mm-1 (R2 = 90.1%).
However, analysis of individual sample development
from day 10 through day 44 revealed different pat-
terns for different samples, ranging from linear
(BS/BV(t[day]) = (-0.9t + 61.6) mm-1, R2 = 88.1%)
to strictly exponential (BS/BV(t[day]) = 158.7e-0.042t
mm-1, R2 = 95.2%).
Structure Model Index
Over the culture period the mean SMI dropped
from 3.18 to 2.59 (ideal spheres: SMI = 4, ideal rods:
SMI = 3, ideal plates: SMI = 0, Fig. 3c), suggesting
structure development from sphere-like nodules to-
wards more rod- and plate-like. For the development
of SMI over time, no mathematical pattern could be
found for pooled data. Regarding individual data, the
curves of most samples followed a linear trend, while
others were inconsistent and did not follow a general
trend.
FIGURE 1. (a) Individual sample data showing 3D top view images of three representative samples at days 10, 17, 28, and 44, as
imaged using lCT, (b) corresponding bone volume over time, and (c) corresponding relative bone volume over time.
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Trabecular Thickness and Trabecular Spacing
Pooled data indicated a steady increase in trabecular
thickness over the whole culture period from 0.072 to
0.146 mm (Fig. 3d). For pooled samples, Tb.Th as a
function of time followed a logarithmic pattern, with
Tb.Th(t[day]) = (0.058Ln(t) - 0.078) mm(R2 = 98.7%).
While individually most samples also followed a log-
arithmic pattern, data revealed an interim drop in
trabecular thickness for 2 of the 11 samples. Mean
trabecular spacing decreased from 1.58 to 0.94 mm,
while individual data showed a rather unsteady
development of trabecular spacing for individual
samples (Fig. 3e).
Tissue Mineral Density
Based on pooled data tissue mineral density in-
creased linearly over time (R2 = 96%) following
TissueMineralDensityðt½dayÞ ¼ ð172þ tÞmgHA/cm3,
as shown in Fig. 3f.
Eﬀect of lCT Imaging on Cell Performance
DNA content per scaﬀold of the non-irradiated
control group (94.6 ± 50.3 lg, n = 10) and the
irradiated group (87.9 ± 15.5 lg, n = 10) were not
signiﬁcantly different after 28 days of culture and
seven repetitive lCT-based imaging cycles (Fig. 4b).
No signiﬁcant irradiation effect was found for alka-
line phosphatase activity per DNA (AP activity,
0.38 ± 0.19 and 0.42 ± 0.09, respectively; n = 10) or
calcium deposition per scaffold (235.4 ± 77.5 lg and
272.7 ± 100.2 lg, respectively; n = 10). Also mor-
phometrical data achieved from lCT imaging did not
reveal signiﬁcant differences in cell performance due to
multiple irradiation (Figs. 4a and 4b).
DISCUSSION
This study was based on the hypothesis that in vitro
bone-like tissue formation can be visualized and
quantiﬁed on hMSC-seeded SF scaffolds using lCT
imaging. This is based on lCT imaging as an integral
tool for the qualitative and quantitative evaluation of
bone implants, using tissue engineering approaches.
Moreover, this work was motivated by the need to
provide feasibility data leading towards the develop-
ment of an imaging interface, which can provide im-
age-guided input parameters for future bioreactors.
Feeding image-derived tissue information into algo-
rithms may guide the continuous adaptation of med-
ium composition, physical, and chemical stimuli in an
automated and feedback mode to optimize the engi-
neering of bone implants.
The surface antigen pattern of expanded cells, iso-
lated from human bone marrow, were typical for
hMSCs and demonstrated the cells capacity to selec-
tively diﬀerentiate along osteogenic and chondrogenic
lineages, respectively.19,25 Based on this pattern of
FIGURE 2. Superimposed 3D bone volumes of two representative samples illustrating the progression of bone-like tissue
deposition: (a–b) Top views and (c–d) side views on corresponding center slices; blue = bone volume (BV) at day 14, green = BV at
day 28, red = BV at day 44, as imaged using lCT.
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surface antigen expression and selective differentiation
this cell isolate was referred to as hMSCs in this study.
From the total of 15 constructs (three vials each
containing ﬁve constructs), which were scanned from
day 7 through day 44, 11 constructs were well ﬁxed in
place for the whole culture period and, therefore, could
be easily used for repetitive imaging analysis. Trabec-
ular bone-like structures were tissue engineered
(Figs. 1 and 2). Pooled data illustrated a steady
increase of average BV/TV over time, as intuitively
expected and corroborating previous reports
(Fig. 3a).4 Large standard deviations were observed,
although particular care was taken to standardize the
experimental steps by using the same operator, the
same batch of scaffolds, and the same course of cell
seeding, cell number, medium supply, and imaging.
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FIGURE 3. Results from full morphometric lCT analysis. Pooled (top) and individual (bottom) data from 11 samples: (a) bone
volume density, (b) bone surface-to-volume ratio, (c) structure model index, (d) trabecular thickness, (e) trabecular spacing, and (f)
tissue mineral density.
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However, only the individual assessment of samples
over time, avoiding destructive end-point data collec-
tion, revealed the different tissue deposition patterns
for each sample. To our knowledge, this study presents
for the ﬁrst time detailed, quantitative data on the
progression of bone-like tissue formation of individual
samples (Fig. 3).
Bone-like tissue growth was visualized by superim-
posing lCT images taken from three consecutive time
points (Fig. 2). Bridging of bone-like components and,
therefore, structure development was observed with
highest bone volume densities at the periphery of the
scaffolds, as reported elsewhere for static cultures.4,13
In former studies the cell distribution, proliferation,
and activity after static Matrigel-based seeding and D-
MEM-based seeding, respectively, onto salt-leached
SF scaffolds was evaluated.11,34 A homogeneous cell
distribution throughout the scaffold was observed
within pore sizes ranging between 112 and 700 lm.
Therefore, the peripheral preference of the mineralized
matrix deposition cannot be assumed to arise from
initial cell distribution. Instead, limited ingrowth into
the scaffold may be explained by different diffusion
access for nutrition and gas, or inhibited cell migration
to the center among samples. Diffusion could have
been blocked in some cases by the initial scaffold
geometry or cellular sheets occluding the pores inter-
connectivity4,14 and might not necessarily reﬂect dif-
ferences in the osteogenic potential but rather
differences in scaffold homogeneity. Image-guided
optimization could possibly be developed into a useful
tool to improve protocols resulting in the homogenous
formation of bone-like tissue. In spite of the hetero-
geneous tissue formation process among the samples,
evidence was demonstrated that initial BV was not
predictive for overall bone volume after 44 days of
culture (Figs. 1–3). This indicates the need for a non-
invasive imaging approach to determine the best time
for sample harvesting or intervention.
Mean bone surface-to-volume ratio (BS/BV) drop-
ped throughout the culture period (from 80.0 to
26.1 mm-1, Fig. 3b). An explanation could be the
deposition of several small seeding sites at the begin-
ning. With progression of tissue culture, mineralized
clusters merged, resulting in fewer particles, but larger
particle volumes and, therefore, decreasing their sur-
face-to-volume ratio. The decreasing variation in
BS/BV over time also indicated a biological control
process aiming at a certain bone surface-to-volume
ratio. This was corroborated by the course of the
BS/BV ratio for individual samples (Fig. 3b). These
samples, all starting with different BS/BV at day 10,
resulted in a common value of approximately 26 mm-1.
Further studies are needed to detail the absolute value
of 26 mm-1 and its variation dependent on issues such
as scaffold properties, medium composition, donor or
chemical, and physical stimulation.
The decrease in SMI from 3.2 to 2.6 indicated a
structure development towards rods and plates from
an initially more sphere-like structure. An explanation
for the initially higher SMI are the new appearing
bone-like clusters which are sphere-like and predomi-
nant in the beginning of the culture. With progression
of the culture the established bone-like clusters grow
and are geared to the surface of the scaﬀold. Accord-
ingly, they tend to form rod- and plate-like structures.
But the extrapolation of the monitoring suggests a
further decrease in SMI. It is most likely, that the
structure of the scaﬀold inﬂuences directly the ﬁnal
SMI of the deposited bone-like tissue.
Trabecular thickness increased towards a mean of
0.146 mm. The varying values for Tb.Sp as they ap-
pear for the individual data could appear from either
predominant newly formed clusters (Tb.Sp suddenly
decreases) or merging of clusters, which were close to
each other (Tb.Sp suddenly increases).
Mean tissue mineral density determined within the
deﬁned BV increased linearly between day 10 and day
FIGURE 4. Effect of lCT imaging on cell performance. (a) Mineralized tissue volume of a formerly non-irradiated control sample at
day 28 as imaged using lCT. Compare to scans of monitored samples at day 28 in Fig. 1. (b) Quantitative comparison of irradiated
group to non-irradiated control group regarding biochemical assays (DNA, AP activity per DNA, Ca content) and morphological
parameters (BV/TV, BS/BV, SMI, Tb.Th, Tb.Sp). All values given in percent and normalized to mean of irradiated group.
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44 (Fig. 3f), demonstrating the continuous minerali-
zation of the tissue. The deviations in tissue mineral
density between the samples were rather small. At this
point monitoring systems enable the presentation of
new parameters like tissue mineralization rate, which
in this study is dTMDdt ¼ 1 mgHAccmday. To exclude partial
volume effects, which make voxels around the vol-
umes surface appear in a slightly wrong gray value,
two voxels were peeled from the surface before deter-
mination of the tissue mineral density, as recom-
mended by the lCT manufacturer. Since for this study
resolution (36 lm) was rather coarse compared to
mean trabecular thicknesses (72–146 lm), a signiﬁcant
amount of the bone volume was removed due to
peeling. Therefore, only general trends but no exact
data on TMD can be reported. To make TMD deter-
mination a powerful tool in the future, e.g. to study
bone formation and mineralization at the surface of
the tissue in more detail, resolution has to be further
improved while lCT measurement times have to re-
main brief, to not keep the tissue out of the incubator
for too long.
Based on detailed quantiﬁcation, the engineered
tissues morphology could be compared to human
biopsy data (Table 19). At day 44, BV/TV of the tissue-
engineered constructs ranged between 2% and 26%
and therefore well within physiological BV/TV values
for human trabecular bone, which range between 4%
and 48% depending on the anatomical site. Concern-
ing BS/BV (average value of 26 mm-1 in vitro), human
bone biopsies measurements revealed values between 7
and 34 mm-1 depending on the harvest site. Compared
to the SMI of human trabecular bone, which is
approximately 2.1 at the lumbar spine and 0.4 at the
femoral head, the SMI within this study is still rather
high. The achieved average of 0.147 mm for Tb.Th is
identical to human physiological values for trabecular
bone (mean Tb.Th in trabecular bone from iliac crest,
lumbar spine, femoral head, and calcaneal core:
Tb.Th = 0.147 mm). At the end of the culture period
the trabecular spacing range in vitro (0.43–1.32 mm)
matched well with the human physiological range
(0.45–1.31 mm). However, concerning all morpholog-
ical evaluations performed in this in vitro study, it has
to be kept in mind, that the samples distribution of
mineralization was not homogeneous throughout the
constructs. Even when mineralization is inhomoge-
neous, BS/BV, SMI, and Tb.Th are the same locally as
they are globally. This is not the case for BV/TV and
Tb.Sp. Nevertheless, BV/TV and Tb.Sp are important
parameters to judge on the global quality of the engi-
neered tissue. To be able to quantitatively monitor the
mineralization homogeneity, the standard deviation of
Tb.Sp within each sample might be an appropriate
index in future studies.
The impact of irradiation on osteogenic cell per-
formance was assessed. Eﬀects of ionizing irradiation
on gene expression (e.g. Telomerase, c-myc, c-jun, IL-
6) and DNA strand breaks in human cells were re-
ported from doses in the order of 0.1 mGy or larger
and after 1–14 days.3,6,8,24,28 Depending on exposure
time, lCT as used in the present study exposes speci-
mens to X-ray doses in the order of 0.1–1 Gy (data not
shown) and, therefore, risk is present. The biochemical
evaluations completed here are insufﬁcient to assess
this risk e.g. of malignic transformations.27 Further-
more, multiple exposures as used in this study further
enhance potential pathological cell alterations. We
conﬁned the biochemical assessment to cellular osteo-
genic performance, when exposed to X-ray. In this
study, cellular proliferation and calcium deposition
were not inﬂuenced after seven lCT cycles, a ﬁnding
corroborating previous reports.4 However, since DNA
content was only measured at one time-point and
showed large standard deviation, the presented data on
DNA content provide a low statistical power for ﬁnally
discerning potential differences in cell proliferation due
to lCT monitoring. Also morphometrical development
of the tissue was not signiﬁcantly inﬂuenced by irra-
diation. The goal of this study was not to demonstrate
that the integral use of lCT can be generally recog-
nized as a safe tool. Eventual use of lCT or the
assessment of implants must be accompanied by
genotox studies and other toxicological evaluations.
However, the biochemical data suggested that an
analysis of temporal and spatial mineralization events
was possible without inducing alterations in osteogenic
patterns, an encouraging ﬁrst step in this process.
TABLE 1. Comparing morphometric indices of in vitro-engineered bone-like tissue to human trabecular bone9.
Index
In vitro-engineered bone-like tissue at day 44 Human biopsies
Mean Min Max Mean Min Max
BV/TV (%) 10 2 26 14 4 48
BS/BV (mm-1) 26 20 38 20 7 34
Tb.Th (mm) 0.146 0.112 0.172 0.147 0.082 0.284
Tb.Sp (mm) 0.937 0.422 1.317 0.742 0.454 1.308
SMI (1) 2.6 2.2 3.4 1.5 -0.7 2.9
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Besides the irradiation dose as a limiting factor also
imaging time and imaging resolution are crucial
parameters for clinical applications. With the pro-
spective development of faster lCT systems, imaging
times will get shorter. On the one hand, this would
enable to shorten the samples time outside the incu-
bator and, therefore, be less disturbing to the tissue.
On the other hand, imaging resolution could get
higher, which allows a more detailed tissue analysis,
i.e. regarding TMD.
The results of this study demonstrated the feasibility
of monitoring and quantifying the formation of in vi-
tro-engineered bone-like tissue from hMSC by the
integral use of lCT. Trabecular bone-like tissue was
grown, visualized in situ, and its morphology was
found to lie well within human physiological ranges.
To make general conclusions about bone formation
in situ from the detailed individual quantiﬁcation,
sample numbers are probably too low. But this setup
enables further investigations of phenomena like ﬁnal
surface-to-volume ratio or SMI development. In the
future, individual monitoring of morphology and
mineralization over time should enable feedback loops
with controlled bioreactors and the generation of
homogenously mineralized implants. We are aiming
for the tuning of certain morphometrical indices
towards predetermined values during the culture.
Furthermore, this process can result in advanced test
systems, detailing drug action on tissue performance.
However, detailed studies on the genotoxicological
potential for the described setting are needed, before
embarking into a lCT based and image guided future
of bone tissue engineering.
ACKNOWLEDGMENTS
Financial support from ETH Zurich (TH 26.04-1),
the Association for Orthopedic Research (AFOR), and
the NIH Tissue Engineering Resource Center are
greatly appreciated. We thank Dr. Martin Stauber for
help in AVS illustration, Trudel Inc. for silk cocoons,
and Wyeth Biopharmaceuticals for BMP-2 supply.
REFERENCES
1Alsberg, E., E. E. Hill, and D. J. Mooney. Craniofacial
tissue engineering. Crit. Rev. Oral Biol. Med. 12:64–75,
2001.
2Asakura, A., M. Komaki, and M. Rudnicki. Muscle sa-
tellite cells are multipotential stem cells that exhibit myo-
genic, osteogenic, and adipogenic differentiation.
Differentiation 68:245–253, 2001.
3Beetz, A., G. Messer, T. Oppel, D. van Beuningen, R. U.
Peter, and P. Kind. Induction of interleukin 6 by ionizing
radiation in a human epithelial cell line: control by corti-
costeroids. Int. J. Radiat. Biol. 72:33–43, 1997.
4Cartmell, S., K. Huynh, A. Lin, S. Nagaraja, and R.
Guldberg. Quantitative microcomputed tomography
analysis of mineralization within three-dimensional scaf-
folds in vitro. J. Biomed. Mater. Res. A 69:97–104, 2004.
5Demarteau, O., D. Wendt, A. Braccini, M. Jakob, D.
Schafer, M. Heberer, and I. Martin. Dynamic compression
of cartilage constructs engineered from expanded human
articular chondrocytes. Biochem. Biophys. Res. Commun.
310:580–588, 2003.
6Enomoto, A., N. Suzuki, Y. Kang, K. Hirano, Y. Mat-
sumoto, J. Zhu, A. Morita, Y. Hosoi, K. Sakai, and H.
Koyama. Decreased c-Myc expression and its involvement
in X-ray-induced apoptotic cell death of human T-cell
leukaemia cell line MOLT-4. Int. J. Radiat. Biol. 79:589–
600, 2003.
7Freyria, A. M., Y. Yang, H. Chajra, C. F. Rousseau, M. C.
Ronziere, D. Herbage, and A. J. El Haj. Optimization of
dynamic culture conditions: effects on biosynthetic activi-
ties of chondrocytes grown in collagen sponges. Tissue Eng.
11:674–684, 2005.
8Hallahan, D. E., E. Dunphy, J. Kuchibhotla, A. Kraft, T.
Unlap, and R. R. Weichselbaum. Prolonged c-jun expres-
sion in irradiated ataxia telangiectasia ﬁbroblasts. Int. J.
Radiat. Oncol. Biol. Phys. 36:355–360, 1996.
9Hildebrand, T., A. Laib, R. Mu¨ller, J. Dequeker, and P.
Ru¨egsegger. Direct three-dimensional morphometric anal-
ysis of human cancellous bone: microstructural data from
spine, femur, iliac crest, and calcaneus. J. Bone Miner. Res.
14:1167–1174, 1999.
10Hildebrand, T., and P. Ruegsegger. Quantiﬁcation of bone
microarchitecture with the structure model index. Comput.
Methods Biomech. Biomed. Eng. 1:15–23, 1997.
11Hofmann, S., H. Hagenmuller, A. M. Koch, R. Muller, G.
Vunjak-Novakovic, D. L. Kaplan, H. P. Merkle, and L.
Meinel. Control of in vitro tissue-engineered bone-like
structures using human mesenchymal stem cells and porous
silk scaffolds. Biomaterials 28:1152–1162, 2007.
12Hollinger, J. O., S. Winn, and J. Bonadio. Options for
tissue engineering to address challenges of the aging skel-
eton. Tissue Eng. 6:341–350, 2000.
13Ishaug, S. L., G. M. Crane, M. J. Miller, A. W. Yasko, M.
J. Yaszemski, and A. G. Mikos. Bone formation by three-
dimensional stromal osteoblast culture in biodegradable
polymer scaffolds. J. Biomed. Mater. Res. 36:17–28, 1997.
14Ishaug-Riley, S. L., G. M. Crane-Kruger, M. J. Yaszemski,
and A. G. Mikos. Three-dimensional culture of rat calv-
arial osteoblasts in porous biodegradable polymers. Bi-
omaterials 19:1405–1412, 1998.
15Karageorgiou, V., M. Tomkins, R. Fajardo, L. Meinel, B.
Snyder, K. Wade, J. Chen, G. Vunjak-Novakovic, and D.
L. Kaplan. Porous silk ﬁbroin 3-D scaffolds for delivery of
bone morphogenetic protein-2 in vitro and in vivo.
J. Biomed. Mater. Res. A 78:324–334, 2006.
16Martin, I., D. Wendt, and M. Heberer. The role of biore-
actors in tissue engineering. Trends Biotechnol. 22:80–86,
2004.
17Meinel, L., R. Fajardo, S. Hofmann, R. Langer, J. Chen,
B. Snyder, G. Vunjak-Novakovic, and D. Kaplan. Silk
implants for the healing of critical size bone defects. Bone
37:688–698, 2005.
HAGENMU¨LLER et al.1666
18Meinel, L., S. Hofmann, O. Betz, R. Fajardo, H. P. Merkle,
R. Langer, C. H. Evans, G. Vunjak-Novakovic, and D. L.
Kaplan. Osteogenesis by human mesenchymal stem cells
cultured on silk biomaterials: comparison of adenovirus
mediated gene transfer and protein delivery of BMP-2.
Biomaterials 27:4993–5002, 2006.
19Meinel, L., V. Karageorgiou, R. Fajardo, B. Snyder, V.
Shinde-Patil, L. Zichner, D. Kaplan, R. Langer, and G.
Vunjak-Novakovic. Bone tissue engineering using human
mesenchymal stem cells: effects of scaffold material and
medium ﬂow. Ann. Biomed. Eng. 32:112–122, 2004.
20Meinel, L., V. Karageorgiou, S. Hofmann, R. Fajardo, B.
Snyder, C. Li, L. Zichner, R. Langer, G. Vunjak-No-
vakovic, and D. L. Kaplan. Engineering bone-like tissue
in vitro using human bone marrow stem cells and silk
scaffolds. J. Biomed. Mater. Res. A 71:25–34, 2004.
21Mu¨ller, R., T. Hildebrand, and P. Ru¨egsegger. Non-inva-
sive bone biopsy: a new method to analyse and display the
three-dimensional structure of trabecular bone. Phys. Med.
Biol. 39:145–164, 1994.
22Mu¨ller, R., and P. Ru¨egsegger. Micro-tomographic
imaging for the nondestructive evaluation of trabecular
bone architecture. Stud. Health Technol. Inform. 40:61–79,
1997.
23Nazarov, R., H. J. Jin, and D. L. Kaplan. Porous 3-D
scaffolds from regenerated silk ﬁbroin. Biomacromolecules
5:718–726, 2004.
24Neuhof, D., A. Ruess, F. Wenz, and K. J. Weber. Induc-
tion of telomerase activity by irradiation in human lym-
phoblasts. Radiat. Res. 155:693–697, 2001.
25Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal,
R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simo-
netti, S. Craig, and D. R. Marshak. Multilineage potential
of adult human mesenchymal stem cells. Science 284:143–
147, 1999.
26Risbud, M. V., and M. Sittinger. Tissue engineering: ad-
vances in in vitro cartilage generation. Trends Biotechnol.
20:351–356, 2002.
27Ritman, E. L. Micro-computed tomography-current status
anddevelopments.Annu.Rev.Biomed.Eng.6:185–208, 2004.
28Rogakou, E. P., C. Boon, C. Redon, and W. M. Bonner.
Megabase chromatin domains involved in DNA double-
strand breaks in vivo. J. Cell Biol. 146:905–916, 1999.
29Ru¨egsegger, P., B. Koller, and R. Mu¨ller. A microtomo-
graphic system for the nondestructive evaluation of bone
architecture. Calcif. Tissue Int. 58:24–29, 1996.
30Seifert, B., G. Mihanetzis, T. Groth, W. Albrecht, K. Ri-
chau, Y. Missirlis, D. Paul, and G. von Sengbusch.
Polyetherimide: a new membrane-forming polymer for
biomedical applications. Artif. Organs 26:189–199, 2002.
31Sikavitsas, V. I., G. N. Bancroft, J. J. Lemoine, M. A.
Liebschner, M. Dauner, and A. G. Mikos. Flow perfusion
enhances the calciﬁed matrix deposition of marrow stromal
cells in biodegradable nonwoven ﬁber mesh scaffolds. Ann.
Biomed. Eng. 33:63–70, 2005.
32Singh, H., S. H. Teoh, H. T. Low, and D. W. Hutmacher.
Flow modelling within a scaffold under the inﬂuence of
uni-axial and bi-axial bioreactor rotation. J. Biotechnol.
119:181–196, 2005.
33Vunjak-Novakovic, G., L. Meinel, G. Altman, and D.
Kaplan. Bioreactor cultivation of osteochondral grafts.
Orthod. Craniofac. Res. 8:209–218, 2005.
34Wang, Y., U. J. Kim, D. J. Blasioli, H. J. Kim, and D. L.
Kaplan. In vitro cartilage tissue engineering with 3D por-
ous aqueous-derived silk scaffolds and mesenchymal stem
cells. Biomaterials 26:7082–7094, 2005.
35Washburn, N. R., M. Weir, P. Anderson, and K. Potter.
Bone formation in polymeric scaffolds evaluated by proton
magnetic resonance microscopy and X-ray microtomogra-
phy. J. Biomed. Mater. Res. A 69:738–747, 2004.
Time-Lapsed Monitoring of Tissue-Engineered Bone 1667
